Sayeed et al. indicated that aberrant BST2 overexpression promoted the disappearance of TGFβ-mediated tumor-suppressive effects in breast cancer as a consequence and the ensuing loss of the differentiation program (A. Sayeed et al., 2013). The gene discussed is BST2; the disease is breast carcinoma.